Article
Evaluation of BoostDM, a somatic variant prediction tool, for the interpretation of germline variants in hereditary cancer genes.
European journal of human genetics : EJHG - 1 Sept 2026
Munté Elisabet, Muiños Ferran, Marín Raúl, Feliubadaló Lidia, Brando Federica, López-Bigas Núria, Lázaro Conxi, González-Pérez Abel, Valle Laura
Abstract excerpt
Classifying germline variants in hereditary cancer genes remains challenging and requires integrating diverse lines of evidence. BoostDM is a computational method originally developed to identify somatic cancer driver mutations by detecting signals of positive selection. Given the functional overlap between somatic and germline pathogenic variants in cancer genes, we evaluated the utility of BoostDM for...
Read the complete abstract on PubMedTopics
- Humans
- Germ-Line Mutation
- Mutation, Missense
- Genetic Testing
- Genetic Predisposition to Disease
